This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Topadur Pharma Ag. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jeanette Peterke: Innovator in Pharmaceutical Chemistry
Introduction
Jeanette Peterke is a notable inventor based in Schlieren, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds that have therapeutic applications. Her work focuses on enhancing the efficacy of treatments through novel chemical formulations.
Latest Patents
Jeanette Peterke holds a patent for a "Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof." This invention relates to compounds that include specific chemical moieties designed to treat or prevent diseases alleviated by the inhibition of PDE5 in humans and non-human mammals. The patent outlines various formulations and their potential pharmaceutical applications.
Career Highlights
Jeanette is currently associated with Topadur Pharma AG, where she continues to advance her research in pharmaceutical innovations. Her work has led to the development of compounds that are crucial in the treatment of various medical conditions, showcasing her expertise and dedication to improving healthcare outcomes.
Collaborations
Throughout her career, Jeanette has collaborated with esteemed colleagues such as Guido Koch and Reto Naef. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Jeanette Peterke's contributions to pharmaceutical chemistry exemplify her commitment to innovation and improving health outcomes. Her patent and ongoing work at Topadur Pharma AG highlight her role as a leading inventor in her field.